Skip to content

Practicality and relevance of the SNIP in patients with neuromuscular disease.

Practicality and relevance of the SNIP in patients with neuromuscular disease. - Practicality SNIP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON30918
Enrollment
145
Registered
2007-05-15
Start date
2007-06-04
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inspiratory muscle strength respiratory function in patients with neuromuscular disease

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
2 Years to 99 Years

Inclusion criteria

Inclusion criteria: Neuromuscular disease with a risk of nocturnal hypoventilation

Exclusion criteria

Exclusion criteria: Home mechanical ventilation

Design outcomes

Primary

MeasureTime frame
Description of the values of the SNIP in patients with neuromuscular diseases. The feasibility of the SNIP in patients with neuromuscular disease in comparison with the VC and MIP.

Secondary

MeasureTime frame
The feasibility of the SNIP in children and ALS patients in comparison with the VC and MIP. The practicality of the SNIP from the perspective of the patient and the performer of the tests.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)